IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24,463 | -37.3% | 4,932 | -39.8% | 0.01% | -60.0% |
Q1 2022 | $39,000 | +14.7% | 8,194 | +77.5% | 0.02% | +25.0% |
Q4 2021 | $34,000 | +240.0% | 4,616 | +166.1% | 0.02% | +166.7% |
Q3 2021 | $10,000 | -50.0% | 1,735 | -41.5% | 0.01% | -53.8% |
Q2 2021 | $20,000 | +100.0% | 2,966 | +132.8% | 0.01% | -18.8% |
Q1 2021 | $10,000 | – | 1,274 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |